Chengdu AlpVHHs Co., Ltd.
EN
Home>  Pipeline

Pipeline Introduction

AlpVHHs has developed and characterized a portfolio of single-domain antibodies targeting proteins with high therapeutic potential, including CD19, BCMA, PD1, and PDL1 etc. We are now seeking B2B partnerships to further develop these antibodies or co-create new candidates. If you are interested in exploring collaboration opportunities, please contact us.

ProjectApplicationImmunizationLibraryScreening

Vitro Assay

Humanization

Code

Target

BS006Claduin 18.2Gastric CancerPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS007CD16Tumor Immunology, Autoimmune Diseases, Infectious DiseasesPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS009CD28CAR-T, Autoimmune DiseasesPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS014CD7Tumor ImmunologyPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS016GPRC5DMMPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS019CD70Tumor Immunology, Autoimmune DiseasesPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS025Nectin-4ADCPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS026CD38MMPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS027MUC16Diagnosis and Disease Surveillance, Immunotherapy，ADCPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS032HBsAgDiagnostic / Monitoring IndicatorsPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS035SEZ6Tumor Immunology, CAR-TPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS038PSMAProstatic CancerPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS040CD19Bispecific Antibody, CAR-TPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS041CD5

Diagnostic Markers, Hematologic Malignancies,

 Treatment of Autoimmune Diseases

Pipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS044DLL3Neuroendocrine TumorPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS045CCR8Tumor ImmunologyPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS0525T4 / TPBGTumor ImmunologyPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS059Claduin 18.2Gastric CancerPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS060Trop2ADCPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS072PD-L1Tumor ImmunologyPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS073CD38MMPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS074B7H3Tumor ImmunologyPipeline IntroductionPipeline IntroductionPipeline Introduction

BS078HSADrug Delivery Vehicles, ExcipientsPipeline IntroductionPipeline IntroductionPipeline Introduction

BS079TFRTargeted Drug DeliveryPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS081BCMAMMPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS085CD3Bispecific AntibodyPipeline IntroductionPipeline Introduction


BS087TSLPTargeted Therapy for Type 2 Inflammatory DiseasesPipeline IntroductionPipeline IntroductionPipeline Introduction

BS088CDH17Gastrointestinal CancerPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS090CLL1AMLPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS091HER3Bispecific Antibody, ADCPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS092CD20Targeted Therapy for TumorsPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS093PD-1Tumor ImmunologyPipeline IntroductionPipeline Introduction


BS097TSHRAutoimmune DiseasePipeline IntroductionPipeline IntroductionPipeline Introduction

BS098CD146Diagnosis / Prognosis MarkersPipeline IntroductionPipeline IntroductionPipeline IntroductionPipeline Introduction
BS099STEAP1ADCPipeline Introduction